Interim Immunization Recommendations for Emergency Responders to Hurricane Katrina

Article

According to the Centers for Disease Control and Prevention (CDC), required immunizations for emergency responders include:

--Tetanus and diphtheria toxoid (receipt of primary series, and Td booster within 10 years)

-- Hepatitis B vaccine series for persons who will be performing direct patient care or otherwise expected to have contact with bodily fluids

There is no indication for the following vaccines given the anticipated conditions in the region:

-- Hepatitis A vaccine (low probability of exposure, even under these conditions, in the U.S. ) No transmission from contaminated water has been identified in the U.S. since the 1980's. Hepatitis A outbreaks have not occurred following other hurricanes or floods in other parts of the country, including the devastating hurricanes in Florida last year, and the Midwestern floods of the late 1990s. The gulf region has had few hepatitis A cases in recent years, with less than 10 in the past three months reported from the New Orleans area. Thus, even though the water and sewage systems are damaged or out of operation in many areas along the Gulf Coast, the risk of a hepatitis A epidemic is extremely low. The vaccine will take at least one to two weeks to provide substantial immunity.

-- Typhoid vaccine (low probability of exposure, even under these conditions, in U.S.).

-- Cholera vaccine (low probability of exposure, even under these conditions, in U.S., plus no licensed cholera vaccine available in the U.S.).

-- Meningococcal vaccine (no expectation of increased risk of meningococcal disease among emergency responders).

-- Rabies vaccine series (the full series is required for protection). Persons who are exposed to potentially rabid animals should be evaluated and receive standard post-exposure prophylaxis, as clinically appropriate.

Source: CDC

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.